A facilitated case-based discussion about the complexities of managing problematic polypharmacy and deprescribing in patients with a progressive, life-limiting illness.
This is a follow on from the polypharmacy webinar series, which lays the foundations of some of the deprescribing tools available and features a generalist case study.
Why it’s important
The National Overprescribing review highlighted that 10% of medicines prescribed in primary care may be inappropriate and those taking 10 or more medicines are 300 times more likely to have a drug related hospital admission, highlighting the importance of deprescribing.
Structured medication reviews (SMRs) improve medication adherence, reduce unnecessary prescriptions, and optimise patient outcomes. By reviewing patient experience, symptoms, medication use, healthcare professionals can minimise risk of harm, limit side effects, and prevent poor health outcomes. This approach ensures that treatments remain appropriate and effective for better management and enhanced quality of life.
What will be covered
- Case-based discussion about undertaking an SMR in patients with a progressive, life-limiting illness
- Insight into a person-centred approach to deprescribing and optimising medicines outcomes for patients with problematic polypharmacy
- Discussion about the challenges that professionals commonly encounter in relation to considering deprescribing for patients with a progressive, life-limiting illness
- If there is time, we will answer questions from the audience, with a focus on those relating to the case study
Speakers
Speakers from SPS and external organisations will facilitate this event
Non-SPS speakers
Michelle Aslett
Specialist Palliative Care Pharmacist, Marie Curie Hospice, West Midlands
SPS speakers
Learn more about our SPS speakers below.